EMSTER KURT VON — SEC insider filings

SEC reporting owner CIK 1252524. 18 insider filings on record with FilingPulse; latest filed 2026-10-16.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-02-01 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vera Therapeutics, Inc. (VERA)Director22 legs · 790,555 sh · $8,714,653—3
CymaBay Therapeutics, Inc. (CBAY)Director6—1 leg · 15,921 sh · $249,67522
Jasper Therapeutics, Inc. (JSPR)Director7—1 leg · 9,075 sh · $13,5246
Iambic Therapeutics, Inc. (IAM)Director2——1
Vaxcyte, Inc. (PCVX)Director1——1

Insider filings — EMSTER KURT VON

FiledFormIssuerReported transactionsSource
2026-10-164Iambic Therapeutics, Inc. (IAM)Grant/award (A): 20,300 (derivative) @ $0EDGAR
2026-10-143Iambic Therapeutics, Inc. (IAM)Holdings only — no transactions reportedEDGAR
2026-08-044Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2025-07-034Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2024-06-104Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2024-03-224CymaBay Therapeutics, Inc. (CBAY)Disposition to issuer (D): 90,000 · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · +7 moreEDGAR
2024-01-264CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 14,010 (derivative) @ $0EDGAR
2023-09-294CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 15,921 @ $5 · Sale (S): 15,921 @ $15.68 · Option exercise (M): 6,357 (derivative) @ $0 · Option exercise (M): 943 (derivative) @ $0 · Option exercise (M): 3,372 (derivative) @ $0 · Option exercise (M): 5,249 (derivative) @ $0EDGAR
2023-06-084Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 47,000 (derivative) @ $0EDGAR
2023-04-144Jasper Therapeutics, Inc. (JSPR)Sale (S): 9,075 @ $1.49EDGAR
2023-01-274CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-10-134Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 30,250 @ $0EDGAR
2022-03-234Jasper Therapeutics, Inc. (JSPR)Grant/award (A): 78,045 (derivative) @ $0EDGAR
2022-01-274CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 67,000 (derivative) @ $0EDGAR
2021-06-034Vaxcyte, Inc. (PCVX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-05-184Vera Therapeutics, Inc. (VERA)Purchase (P): 17,828 @ $12.04 · Conversion (C): 2,187,504 · Purchase (P): 772,727 @ $11 · Conversion (C): 2,187,504 (derivative) @ $0EDGAR
2021-05-174Vera Therapeutics, Inc. (VERA)Grant/award (A): 9,925 (derivative) @ $0EDGAR
2021-02-014CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 32,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1252524 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs